OverlTherapeutics is a cross-border biotechnology company with a mission of accelerating the global development of first best-in- cell therapies. Headquartered in South San Francisco, OverlTx has established fully integrated, cross-border cell therapy research, development, GMP manufacturing capabilities. OverlTx is developing both autologous allogeneic cell therapies to address significant patient unmet needs in hematological mancies autoimmune diseases.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows